JEROME ROBERT

Has grant

Professeur

Sorbonne Université Faculté de Médecine

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Jerome Robert is a faculty member at Sorbonne University Medical School in France. His research focuses on antibiotic resistance, tuberculosis treatment outcomes, and the detection of nontuberculous mycobacteria. He has authored several articles on these topics, contributing to the understanding of drug-resistant infections and their management in clinical settings.

Recent Grants

Grant: Close

PRISMES

Open Date: 2022-06-01

Close Date: 2025-06-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Laurent Dortet

Université Paris-Saclay

FRANCE

View details

Rémy A. Bonnin

Associated professor in Microbiology

Université de Paris Faculté de Santé

FRANCE

View details

Aude Jary

Sorbonne Université

FRANCE

Université Paris Cité

FRANCE

View details

Margaret M Fitzgibbon

Chief Medical Scientist

St George's Hospital

IRELAND

View details

Xavier Nassif

Professor

Université Paris Cité

FRANCE

View details

Anne Marie McLaughlin

Clinical Associate Professor

Trinity College Dublin

IRELAND

View details

Emmanuelle Bille

Université Paris Descartes Faculté de Médecine

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

JEROME ROBERT

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study

Evaluation of imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam and cefepime-zidebactam activities on a wide collection of French clinical Enterobacterales isolates

Standardised protocol for the detection and quantification of nontuberculous mycobacteria (NTM) in tap water and its application in investigating the source of NTM clinical infections

Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment

Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018–2023

Re: ‘Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe’ by Lange et al.

<i>Mycobacterium chelonae</i> cutaneous infections unrelated to invasive procedures: A multicentre retrospective case series

Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution

Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB

A predictive score for the result of carbapenem-resistant Enterobacterales and vancomycin-resistant enterococci screening

Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor

Pharmacokinetics/pharmacodynamics of ceftobiprole in patients on extracorporeal membrane oxygenation

Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022

Impact de la première année de la pandémie de COVID-19 sur l’épidémiologie des infections invasives (bactériémies) dans les hôpitaux de l’Assistance Publique–Hôpitaux de Paris

Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region.

Early-onset neonatal sepsis in the Paris area: a population-based surveillance study from 2019 to 2021.

Investigation of healthcare-associated COVID-19 in a large French hospital group by whole-genome sequencing

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019

Increased linezolid plasma concentrations are associated with the development of severe toxicity in MDR-TB treatment.

Collaborators (13)

Laurent Dortet

Rémy A. Bonnin

Aude Jary

Thierry Naas

David Skurnik

vincent jarlier

Rita Macedo

Jean-Louis Herrmann

Asmaa Tazi

Margaret M Fitzgibbon

Xavier Nassif

Anne Marie McLaughlin

Emmanuelle Bille

Make your next move.